Anti-IL-20 antibodies and binding partners and methods of using in inflammation
US8907068B2 · kind B2 · utility
0Cited by
9References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 21, 2008 |
| Grant date | Dec 9, 2014 |
| Priority date | — |
| Expiry date | Feb 20, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to blocking the activity of IL-20 polypeptide molecules. IL-20 is a cytokine that is involved in inflammatory processes and human disease. IL-20RA/IL-20RB is a common receptor for IL-20. The present invention includes anti-IL-20 antibodies and binding partners, as well as methods for antagonizing IL-20 using such antibodies and binding partners.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.